Infrequent occurrence of this unique JAK2 mutation has been reported recently in chronic myeloid leukemia (CML), acute myelocytic leukemia, and acute lymphoblastic leukemia (Jones et al., 2005). This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.